PharmaCyte Biotech, Inc. (85) | Human Resources (5)
Browse by Subcategory
Recent Contracts
-
Separation, Consulting and Release Agreement, dated October 6, 2022, by and between PharmaCyte Biotech, Inc. and Kenneth L. Waggoner
(Filed With SEC on October 7, 2022)
-
Amended and Restated Executive Compensation Agreement, dated May 8, 2022, between Kenneth L. Waggoner and the Company
(Filed With SEC on July 28, 2022)
-
Amended and Restated Executive Compensation Agreement, dated May 8, 2022, between Carlos A. Trujillo and the Company
(Filed With SEC on July 28, 2022)
-
PharmaCyte Biotech, Inc. 2021 Equity Incentive Plan
(Filed With SEC on July 28, 2022)
-
Amendment No. 3, dated as of October 14, 2020, to Executive Compensation Agreement between Gerald W. Crabtree and the Company
(Filed With SEC on October 16, 2020)